N-Cyclodecyl-acetamide | 31510-03-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: N-Cyclodecyl-acetamide
• 英文别名: N-cyclodecylacetamide
• CAS: 31510-03-9
• 化学式: C₁₂H₂₃NO
• 分子量: 197.321
• InChiKey: CDGTYMSJDCSQHI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.92
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

文献信息

• [EN] MALT1 MODULATORS AND USES THEREOF<br/>[FR] MODULATEURS DE MALT1 ET LEURS UTILISATIONS
  申请人：RHEOS MEDICINES INC

  公开号：WO2021138298A1

  公开（公告）日：2021-07-08

  Provided herein are compounds, compositions, and methods useful for modulating MALT1 and for treating related diseases, disorders, and conditions.

  本文提供了一些有用于调节MALT1并用于治疗相关疾病、疾病和症状的化合物、组合物和方法。
• [EN] INHIBITORS OF INTEGRIN ALPHA 2 BETA 1 AND METHODS OF USE<br/>[FR] INHIBITEURS DE L'INTÉGRINE ALPHA 2 BÊTA 1 ET PROCÉDÉS D'UTILISATION
  申请人：UNIV CALIFORNIA

  公开号：WO2019178248A1

  公开（公告）日：2019-09-19

  Disclosed herein, inter alia, are inhibitors of integrin alpha 2 beta 1 and methods of using the same.

  本文披露了抑制整合素α2β1的方法，以及使用这些方法的方法。
• ADSORBING MATERIAL FOR MULTIPLE PATHOGENIC FACTORS OF SEPSIS AS WELL AS PREPARATION METHOD AND APPLICATION THEREOF
  申请人：Chongqing Zhengbo Biotechnology Co. Ltd.

  公开号：US20190054227A1

  公开（公告）日：2019-02-21

  An adsorbing material for multiple pathogenic factors of sepsis as well as a preparation method and an application thereof are provided. The adsorbing material is formed by coupling a carrier with good mechanical performance and blood compatibility and a ligand with the capacity to adsorb multiple pathogen-associated molecular patterns, and is capable of effectively adsorbing bacterial endotoxin, bacterial genomic DNA, peptidoglycan, lipoteichoic acid, virus RNA, and zymosan from fluids such as blood and the like, and in particular has application value in blood purification for treatment of sepsis.
• [EN] METHODS OF TREATING AUTOIMMUNE DISORDERS AND/OR INFLAMMATORY DISORDERS<br/>[FR] MÉTHODES DE TRAITEMENT DE TROUBLES AUTO-IMMUNS ET/OU DE TROUBLES INFLAMMATOIRES
  申请人：UNIV MICHIGAN

  公开号：WO2010054321A2

  公开（公告）日：2010-05-14

  The present invention relates to dendrimer compositions configured for treating inflammatory disorders and autoimmune disorders, and related methods of synthesis. Specifically, the present invention relates to methods for treating rheumatoid arthritis with PAMAM dendrimers having functional ligands configured for treating rheumatoid arthritis (e.g., therapeutic agents, pro-drugs, targeting agents, trigger agents, imaging agents) (e.g., methotrexate).